Cytokinetics Inc’s recent filing unveils that its President & CEO Blum Robert I unloaded Company’s shares for reported $0.18 million on Apr 10 ’25. In the deal valued at $36.77 per share,5,000 shares were sold. As a result of this transaction, Blum Robert I now holds 422,629 shares worth roughly $16.82 million.
Then, Malik Fady Ibraham sold 2,000 shares, generating $72,360 in total proceeds. Upon selling the shares at $36.18, the EVP Research & Development now owns 140,255 shares.
Before that, FADY MALIK bought 12,000 shares. Cytokinetics Inc shares valued at $431,880 were divested by the Officer at a price of $35.99 per share.
Citigroup initiated its Cytokinetics Inc [CYTK] rating to a Buy in a research note published on February 07, 2025; the price target was $86. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. RBC Capital Mkts began covering CYTK with “an Outperform” recommendation on November 08, 2024. Goldman revised its rating on August 13, 2024. It rated CYTK as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CYTK
On Monday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock jump 3.00% to $39.81. Over the last five days, the stock has gained 10.61%. Cytokinetics Inc shares have fallen nearly -15.37% since the year began. Nevertheless, the stocks have fallen -45.61% over the past one year. While a 52-week high of $73.76 was reached on 01/27/25, a 52-week low of $32.74 was recorded on 04/09/25. SMA at 50 days reached $43.55, while 200 days put it at $50.68.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 38.62, which if violated will result in even more drops to 37.43. On the upside, there is a resistance level at 40.51. A further resistance level may holdings at 41.21. The Relative Strength Index (RSI) on the 14-day chart is 46.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.47%. Stochastics %K at 45.14% indicates the stock is a holding.
How much short interest is there in Cytokinetics Inc?
A steep rise in short interest was recorded in Cytokinetics Inc stocks on 2025-03-31, growing by 0.26 million shares to a total of 14.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 14.07 million shares. There was a rise of 1.82%, which implies that there is a positive sentiment for the stock.
